JPY 2212.0
(-1.86%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 6.35 Billion | 6.02 Billion | 5.21 Billion | 4.54 Billion | 3.38 Billion | 3.3 Billion |
Net Income | 9.85 Billion | 8.5 Billion | 6.09 Billion | 4.74 Billion | 4.18 Billion | 3.74 Billion |
Depreciation & Amortization | 1.48 Billion | 1.01 Billion | 1.09 Billion | 907.34 Million | 868.19 Million | 952.66 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -1.92 Billion | -1.26 Billion | -316.24 Million | 81.26 Million | -289.49 Million | -435.61 Million |
Other non-cash items | -3.06 Billion | -2.22 Billion | -1.65 Billion | -1.19 Billion | -1.37 Billion | -960.14 Million |
Investing Cash Flow | -2.35 Billion | -1.84 Billion | -1.35 Billion | -1.35 Billion | -1.05 Billion | -1.21 Billion |
Investments in PPE | -2.29 Billion | -1.7 Billion | -1.23 Billion | -1.27 Billion | -1 Billion | -1.14 Billion |
Acquisitions | 2.03 Million | 310 Thousand | 1.7 Million | 1.53 Million | 1.69 Million | 2.37 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -55.87 Million | -143.36 Million | -117.31 Million | -89.19 Million | -42.33 Million | -69.11 Million |
Financing Cash Flow | -3.46 Billion | -2.27 Billion | -2.11 Billion | -2.79 Billion | -1.28 Billion | -1.17 Billion |
Debt repayment | - | - | - | - | -2.08 Million | -2.08 Million |
Dividends payments | -3 Billion | -2.19 Billion | -1.66 Billion | -1.45 Billion | -1.28 Billion | -1.16 Billion |
Common Stock Repurchased | -353.59 Million | -261 Thousand | -386.16 Million | -1.29 Billion | -415 Thousand | -952 Thousand |
Common Stock Issuance | - | - | - | - | 2.08 Million | - |
Other Financing Activities | -105.27 Million | -71.97 Million | -59.42 Million | -44.6 Million | -2.08 Million | -2.08 Million |
Accounts receivables | 743.93 Million | -743.11 Million | -361.66 Million | 290.29 Million | -96.01 Million | -384.84 Million |
Accounts payables | -970.07 Million | 564.66 Million | -1.01 Billion | 1.16 Billion | -141.75 Million | 50.03 Million |
Inventory | -1.08 Billion | -1.12 Billion | 670.42 Million | -1.62 Billion | -149.03 Million | -291.11 Million |
Other working capital | -614.47 Million | 38.92 Million | 393.13 Million | 249.95 Million | 97.31 Million | -144.5 Million |
Cash at beginning of period | 13.88 Billion | 11.42 Billion | 9.38 Billion | 9.01 Billion | 8.11 Billion | 7.23 Billion |
Cash at end of period | 14.76 Billion | 13.88 Billion | 11.42 Billion | 9.38 Billion | 9.01 Billion | 8.11 Billion |
Capital Expenditure | -2.29 Billion | -1.7 Billion | -1.23 Billion | -1.27 Billion | -1 Billion | -1.14 Billion |
Effect of forex changes on cash | 337.66 Million | 502.64 Million | 274.54 Million | -22.27 Million | -144.56 Million | -31.97 Million |
Net cash flow / Change in cash | 880.06 Million | 2.46 Billion | 2.04 Billion | 364.91 Million | 903.24 Million | 884.28 Million |
Free Cash Flow | 4.05 Billion | 4.32 Billion | 3.97 Billion | 3.26 Billion | 2.37 Billion | 2.15 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 1.88 Billion | 1.82 Billion | 1.91 Billion | 1.37 Billion | 9.85 Billion | 2.23 Billion |
Depreciation & Amortization | - | - | 364.79 Million | 529.85 Million | 1.48 Billion | 425.65 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | -1.92 Billion | - |
Other non-cash items | -1.88 Billion | -1.82 Billion | -1.91 Billion | -1.37 Billion | -3.06 Billion | -2.23 Billion |
Investing Cash Flow | - | - | - | - | -2.35 Billion | - |
Investments in PPE | - | - | - | - | -2.29 Billion | - |
Acquisitions | - | - | - | - | 2.03 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | -55.87 Million | - |
Financing Cash Flow | - | - | - | - | -3.46 Billion | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | -3 Billion | - |
Common Stock Repurchased | - | - | - | - | -353.59 Million | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -105.27 Million | - |
Accounts receivables | - | - | - | - | 743.93 Million | - |
Accounts payables | - | - | - | - | -970.07 Million | - |
Inventory | - | - | - | - | -1.08 Billion | - |
Other working capital | - | - | - | - | -614.47 Million | - |
Cash at beginning of period | - | - | 14.76 Billion | 12.91 Billion | 13.88 Billion | 12.72 Billion |
Cash at end of period | - | - | 7.67 Billion | 14.76 Billion | 14.76 Billion | 12.91 Billion |
Capital Expenditure | - | - | - | - | -2.29 Billion | - |
Effect of forex changes on cash | - | - | - | - | 337.66 Million | - |
Net cash flow / Change in cash | - | - | -7.09 Billion | 1.85 Billion | 880.06 Million | 184.14 Million |
Free Cash Flow | - | - | 729.59 Million | 1.05 Billion | 4.05 Billion | 851.3 Million |
7609
COIN
ONCO3
THEMISMED
BNL
6549